FDC Limited (BOM:531599)
India · Delayed Price · Currency is INR 356.05
+0.05 (0.01%)
At close: Apr 16, 2026
FDC Limited Market Cap
FDC Limited has a market cap or net worth of 57.96 billion as of April 16, 2026. Its market cap has decreased by -13.82% in one year.
Market Cap
57.96B
Enterprise Value
53.92B
Revenue
20.78B
Ranking
n/a
PE Ratio
26.77
Stock Price
356.05
Market Cap Chart
Since May 30, 2002, FDC Limited's market cap has increased from 2.73B to 57.96B, an increase of 2,025.01%. That is a compound annual growth rate of 13.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 57.96B | -15.90% |
| Dec 31, 2025 | 68.92B | -15.14% |
| Dec 31, 2024 | 81.22B | 25.96% |
| Dec 29, 2023 | 64.48B | 43.15% |
| Dec 30, 2022 | 45.04B | -12.27% |
| Dec 31, 2021 | 51.34B | -8.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 141.32B |
| Rubicon Research | 135.05B |
| Caplin Point Laboratories | 128.17B |
| CORONA Remedies | 96.47B |
| Viyash Scientific | 89.82B |
| Procter & Gamble Health | 82.54B |
| Sanofi India | 79.81B |
| Gufic Biosciences | 30.69B |